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Purpose of review: The incidence of obesity and its related metabolic disorders has increased 22 
significantly over the past 3 decades, culminating in the current global epidemic of metabolic 23 
disease, leading to the search for contributing factors. Exposure of the developing fetus/neonate 24 
to a typical Western diet increases their risk of obesity and metabolic disorders throughout the 25 
life-course, creating an intergenerational cycle of metabolic disease.  In Western countries, this 26 
epidemic of metabolic disease has coincided with a marked increase in the intake of omega-6 27 
polyunsaturated fatty acids (omega-6 PUFA), leading to suggestions that the two may be 28 
causally related. 29 
Recent findings: Recent studies have emphasised the pro-adipogenic properties of the omega-30 
6 PUFA, and provided evidence that rodents fed on diets with omega-6 PUFA contents similar 31 
to the typical US diet (6-8%energy) increased fat mass. Importantly, recent studies have shown 32 
that perinatal exposure to a high omega-6 PUFA diet results in a progressive accumulation of 33 
body fat across generations. 34 
  35 
Summary: This review highlights the recent evidence supporting the role of the omega-6 PUFA 36 
in the early life origins of obesity and metabolic disease, the need for more clinical studies and 37 
the potential need for health agencies to re-evaluate current recommendations to further 38 
increase omega-6 PUFA  intakes. 39 
 40 
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The past decades have seen a substantial increase in the global incidence of obesity and its 45 
related metabolic disorders. In addition to the health and quality of life implications of these 46 
diseases, the direct and indirect costs of these conditions represent a significant economic 47 
burden to countries world-wide [1]. As a result, identifying the causes of this epidemic and 48 
strategies to overcome it has become a major public health priority, and numerous anti-obesity 49 
health campaigns have been launched. To date, however, these campaigns have done little to 50 
successfully combat the problem. 51 
 52 
The importance of quantity and quality of nutritional intake for the regulation of body weight 53 
and fat mass in individuals is widely acknowledged, and has led to suggestions that changes in 54 
the nutritional quality of the typical Western diet is an important driver of the expanding 55 
waistlines of populations world-wide. Whilst good nutrition is important at all life stages, it is 56 
increasingly recognised that the nutritional environment an individual experiences before birth 57 
and in early infancy is of particular importance for their later metabolic health, and that 58 
exposure to an inappropriate nutritional supply during critical windows of development can 59 
predispose an individual to obesity and type 2 diabetes later in life [2, 3]. By extension, the diet 60 
consumed by pregnant and breast-feeding women is a key determinant of the metabolic health 61 
of future generations [4].  62 
 63 
In this review, we will present the temporal and biological evidence underlying the hypothesis 64 
that excess intake of omega-6 PUFA is associated with increases in body fat mass, with a focus 65 
on existing evidence from animal and human studies that exposure to elevated intakes of 66 
omega-6 PUFA before birth or in early infancy can program an increased susceptibility to 67 
obesity throughout the life course. We will highlight the current paucity of human studies 68 
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which have examined the long-term consequences of perinatal exposure to high omega-6 69 
PUFA intakes, and emphasise the need for increased research in order to establish conclusively 70 
whether there is a true causative association.   71 
 72 
Setting the Scene: The Global Epidemic of Obesity and Metabolic Disease 73 
The global incidence of overweight, obesity and metabolic disease nearly doubled in the period 74 
from 1980 to 2008 and continues to increase. In 2008, more than 1.4 billion adults (20 years 75 
and older) and 40 million children under the age of five were overweight and, of these, over 76 
200 million men and nearly 300 million women were obese [1]. This increase in the number of 77 
overweight and obese individuals has been accompanied by a dramatic increase in the 78 
incidence of its associated co-morbidities, including type 2 diabetes and cardiovascular disease. 79 
The significant impact of obesity and its associated metabolic disorders on both the health and 80 
quality of life of sufferers and on the health budgets of economies world-wide has prompted 81 
extensive research to identify factors which have contributed to the epidemic and strategies for 82 
reversing the current trend.  83 
 84 
Both genetic and environmental factors have been implicated in the aetiology of obesity and 85 
metabolic disease. There appears little doubt that genetics plays role in pre-disposing certain 86 
individuals to obesity and metabolic disease, and a there is an ever-growing list of single 87 
nucleotide polymorphisms that confer increased susceptibility to obesity and type 2 diabetes 88 
[5].  However, it is unlikely that there has been any substantial shift in the gene pool of humans 89 
over the relatively short time frame that the obesity epidemic has taken hold, suggesting that 90 
environmental, rather than genetic, factors are likely to play the more important role. Of these 91 
environmental factors, poor dietary habits play a significant role in promoting weight gain and 92 
the accumulation of body fat mass in individuals [6]. However, not all dietary components are 93 
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equal in this regard, and there are some which contribute more to fat accumulation than others, 94 
and there have been numerous attempts to identify those components of the diet which are the 95 
major contributors to weight gain on a population level.  96 
 97 
Examining the Causes: Focus on Fat 98 
It was initially postulated that excessive intake of saturated fat was a key driver of the obesity 99 
epidemic. However, it is now clear that the epidemic of obesity in the US, Australia and other 100 
Western countries has in fact coincided with a significant decline in the per capita intake of 101 
saturated fat, creating somewhat of a problem with this hypothesis. However, as saturated fatty 102 
acid intake has fallen, there has been a corresponding increase in the intake of omega-6 PUFA 103 
in Westernised nations around the world, leading to a significant increase in per capita omega-104 
6 PUFA intake over this time [7]. This shift was initially prompted by the limited availability 105 
of animal-based fats during the Second World War, which led to their replacement with plant-106 
based alternatives, and has since been reinforced by health recommendations which favour 107 
polyunsaturated over saturated fats [8]. In addition, changes in the lipid composition of 108 
formulated animal feeds have led to changes in the fatty acid composition of animal products, 109 
including meat and eggs [9].   110 
 111 
There is growing concern that this increasing dominance of omega-6 PUFA may have negative 112 
consequences for metabolic health. These concerns are based on the biological actions of 113 
omega-6 (linoleic acid (LA); 18:2(n-6) and derivatives thereof), which are largely pro-114 
inflammatory, pro-thrombotic and pro-adipogenic. It has been suggested that increases in 115 
omega-6 PUFA intake over the past few decades may be an important factor contributing to 116 
the current obesity epidemic; in particular there is evidence that exposure to excess omega-6 117 
PUFA before birth or in early infancy may be responsible for promoting fat cell formation early 118 
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in life and thereby predisposing individuals to excess accumulation of body fat as children and 119 
adults [10].  120 
 121 
The Early Life Origins of Obesity 122 
Whilst good nutrition is important at all life stages, a number of critical periods in development 123 
have been identified during which exposure to a sub-optimal nutritional environment are 124 
particularly detrimental, since they can have lasting effects on an individual’s propensity to 125 
develop obesity and metabolic disease later in life. Of these critical windows, the most 126 
important appear to be those that coincide with the major periods of development of the key 127 
metabolic systems, ie. before birth and during the first 2 years of life in humans, and during the 128 
fetal and suckling periods in rodents. Both human and experimental animal studies have shown 129 
that exposure to an inappropriate nutrient supply during these critical windows of development 130 
has life-long consequences for an individual’s health [11]. The early studies of this ‘biological 131 
programming of metabolic disease’, focussed primarily on the effects of sub-optimal nutrition, 132 
either global caloric restriction or low protein, and showed that these exposures were associated 133 
with an increased accumulation of visceral adipose tissue in the offspring and, consequently, a 134 
predisposition to insulin resistance and type 2 diabetes [12].  More recently, attention has 135 
turned to the more common situation in most Western countries; that of maternal overnutrition, 136 
and these studies have demonstrated that exposure to a ‘high-fat’ and/or ‘high-sugar’ diet 137 
before birth or in the early neonatal period predisposes the offspring to obesity and metabolic 138 
disease after birth [2].  139 
 140 
Numerous studies in both large and small animal models have explored the mechanisms 141 
underlying this association, and have demonstrated that altered nutrient supply to the 142 
developing fetus/neonate plays a predominant role. These studies demonstrate that exposure to 143 
7 
 
either excessive calories or an increased supply of fat and/or sugar during critical 144 
developmental windows leads to altered development of key systems involved in the regulation 145 
of energy balance and metabolism which permanently affects their structure and function [2, 146 
13]. These systems include, but are not limited to, the central neural network for appetite 147 
regulation, the fat cell or adipocyte, the mesolimbic reward system and insulin signalling 148 
pathways in skeletal muscle [9, 13]. As a result of these programmed changes in development, 149 
these offspring are hyperphagic, have an increased propensity to accumulate body fat, have a 150 
preference for high-fat and high-sugar foods and are less insulin sensitive [14].  151 
 152 
However, despite the extensive work which has been done in this area, fundamental questions 153 
remain about which specific components of the diet are responsible for these programming 154 
effect, and questions have been raised about the relevance of the common model of high-fat, 155 
high-sugar feeding to typical human diets. In particular, the high-fat diets that are commonly 156 
used in animal studies to induce maternal obesity are high in a number of fatty acid classes, but 157 
there have been limited attempts to dissect out which of the individual fatty acids is responsible 158 
for the programming effects. In the majority of these diets, saturated fat is the main fat 159 
component of the high-fat mix which, from what we have seen in the previous section, may 160 
not in fact be truly reflective of current trends in fatty acid intakes in humans.  However, in our 161 
hands, changes in dietary saturated fat content via the cafeteria diet approach was associated 162 
with an increase in omega-6 PUFA in the maternal milk and offspring plasma (Vithayathil & 163 
Muhlhausler, unpublished observations), and may be playing a central role in the adverse 164 
outcomes of offspring born to mothers who consume high-fat diets during pregnancy and 165 
lactation. 166 
 167 
Omega-6 PUFA and the Adipocyte 168 
8 
 
The hypothesis that increased intake maternal intake of omega-6 PUFA could have 169 
consequences for fat deposition for the fetus or breast-fed offspring has a clear biological basis. 170 
A series of studies have demonstrated the capacity of LA and its long-chain derivative, 171 
arachidonic acid (AA; 20:4(n-6)) to promote the differentiation of pre-adipocytes in vitro, 172 
suggesting that increased exposure to omega-6 PUFA during critical windows in the 173 
development of the adipocyte could result in a permanent increase in the number of adipocytes 174 
in an individual, and thus their propensity to accumulate body fat [15, 16].  These in vitro 175 
studies are supported by experimental animal studies, in which rats provided with diets 176 
containing higher LA levels and/or higher ratios of LA/ALA exhibit an increased expression 177 
of lipogenic genes, increased fat mass and greater adipocyte size and adipocyte number 178 
compared with rats fed a diet containing lower LA levels [17, 18]. Thus, omega-6 PUFA 179 
promoted the expansion of fat depots by upregulating both hyperplasia and hypertrophy. In a 180 
study by Hibbeln and colleagues, mice were fed diets which contained either 1% energy LA or 181 
8% energy LA, similar to the 7-8%en LA found in the typical US diet. Mice consuming the 182 
high LA diet exhibited increased food intake, increased body weight and higher fat mass 183 
compared to those on the 1% LA diet [19]. This provided new evidence that omega-6 PUFA 184 
could promote increases in fat deposition at levels of dietary LA which are commonly 185 
encountered in human diets. 186 
 187 
Omega-6 PUFA and the Early Origins of Obesity 188 
The major period of fat development in human infants occurs before birth and in the first year 189 
of life, with nutritional exposures during this time having permanent consequences for the 190 
regulation of body fat mass throughout life. The established pro-adipogenic role of the omega-191 
6 PUFA forms the basis of the hypothesis that exposure to an increased supply of these fatty 192 
acids during the period of fat cell development could result in permanent programming of 193 
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increased body fat mass. The potential role of omega-6 PUFA in the programming of obesity 194 
is supported by numerous animal studies. In one such study, the offspring of mice fed an LA-195 
rich diet during pregnancy were 40% heavier at weaning than offspring of dams fed on diets 196 
with a balanced LA/ALA ratio [20]. Importantly, this occurred in conjunction with a significant 197 
increase in body fat mass, and was still present in adult life [20]. The potential importance of 198 
the omega-6 PUFA in the intergenerational cycle of obesity has been emphasised by a recent 199 
study by Massiera and colleagues, which demonstrated that feeding rats a diet in which LA 200 
made up 55% of the lipid fraction (19% of total energy) over four generations, led to a 201 
progressive increase in body fat mass in each successive generation, in the absence of any 202 
difference in the intake of saturated fat between the groups [21]. The accumulation of body fat 203 
mass was due to an increase in both the hyperplastic and hypertrophic expansion of the adipose 204 
depots, driven by the upregulation of genes implicated in the hyperplastic and hypertrophic 205 
development of adipose tissue [21]. Importantly, in the guinea pig, which is considered as the 206 
best animal model of adipose tissue growth, increasing the LA/ALA ratio from 2:1 to 30:1 207 
during the pre-weaning period also resulted in increased fat mass in adulthood [22]. 208 
 209 
Since the period of fat cell development extends into the postnatal period in the majority of 210 
species, including humans, the fatty acid composition of the infant diet is also likely to 211 
contribute to the programming of the adipocyte and propensity to obesity. In lactating women, 212 
the fatty acid composition of the maternal diet is reflected in the composition of the breast-213 
milk. Previous studies have demonstrated that women supplemented with omega-3 LCPUFA 214 
accumulate EPA and DHA in their breast milk in proportion with their level of intake [23].  215 
Consequently, the fatty acid composition of breast-milk in Western countries has undergone a 216 
shift in line which that seen in the diet of the general population [7]. Infant formulas have also 217 
undergone a marked evolution in their fatty acid composition over the past 3 decades. Those 218 
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formulas which are now manufactured provide an adequate content of ALA and have a more 219 
balanced LA/ALA ratio, generally ranging between 5 and 10 to 1 [24] (Philippe Guesnet, 220 
personal communication). The Global Standard for the composition of infant formula by a 221 
coordinated group of international experts suggested that the minimum LA level of 2.7% 222 
energy would be adequate to meet requirements [24]. However due to the exclusive use of 223 
vegetable oils in the formulation of infant formulas, the contents of LA in many formulas are 224 
well above physiological requirements, and may be high enough to interfere with omega-3 225 
PUFA metabolism (Philippe Guesnet, personal communication). The International Society for 226 
the Study of Fatty Acids and Lipids (ISSFAL), in their 2008 Statement on Dietary Fats in Infant 227 
Nutrition, stated that the LA content of formulas ranged from between 6% and 25% of total 228 
fatty acids, however acknowledged that, given the potential negative effects of high omega-6 229 
PUFA exposure, further research on high omega-6 formulas was needed [25].  230 
Thus, Western infants, whether breast or formula-fed, are exposed to elevated levels of omega-231 
6 PUFA not only before birth, but also during the early infant period, which could further 232 
exacerbate the effects of these fatty acids on the development of adipose tissue in these 233 
children.   234 
 235 
Evidence from Humans 236 
In humans, most studies have focussed on the effects of increasing omega-3 intake, and there 237 
are currently no clinical studies which have directly investigated the effects of increasing 238 
maternal omega-6 PUFA intake in a randomised controlled trial. In the Project Viva cohort, a 239 
higher omega-6:omega-3 PUFA ratio in umbilical cord blood phospholipids was associated 240 
with a high subscapular skin-fold thickness at 3 years of age [26]. In contrast, a recent 241 
intervention study involving supplementation with EPA and DHA and instruction to lower 242 
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arachidonic acid intake during pregnancy and lactation did not show any effect on infant fat 243 
mass and fat distribution during the first year of life [27]. Further studies should help to solve 244 




The hypothesis that increased maternal intake of omega-6 PUFA could be associated with 249 
adverse metabolic outcomes in her offspring is certainly not new. A series of papers in the mid-250 
2000s focussed on the potential role of the omega-6 PUFAs in the origins of childhood obesity, 251 
and raised several of the points outlined in this review [7, 28-30]. The increase in dietary intakes 252 
of omega-6 PUFA has been documented in several large studies, and has occurred over a time 253 
when the prevalence of obesity in the population has risen sharply, despite declines in the per 254 
capita intake of saturated fat. There is evidence supporting the hypothesis that omega-6 PUFA 255 
have pro-adipogeneic and pro-lipogenic properties, and recent work in animals has 256 
demonstrated that exposure to a high omega-6 PUFA diet during early life is sufficient to 257 
program an increased body fat mass in the offspring.  258 
 259 
Thus far, the work implicating omega-6 PUFA in the programming of obesity appears to have 260 
been largely ignored by health agencies, which continue to advocate the health benefits of 261 
polyunsaturates without identifying the functional differences between omega-6 and omega-3 262 
types [31]. In addition, the potential link between omega-6 PUFA and obesity does not appear 263 
to have challenged the popular belief that saturated fats are ‘bad’ and polyunsaturated fats are 264 
‘good’. It is difficult, as scientists, to understand the reason for this. It is clear, however that 265 
there is an urgent need for human clinical studies, in particular randomized controlled trials, to 266 
conclusively demonstrate whether there is a causal link between maternal omega-6 PUFA 267 
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intakes and health outcomes in children, including obesity and insulin resistance. If causality 268 
is established, then it will be critical to use this as an evidence base for modifying existing 269 
dietary fat recommendations, particularly in light of the fact that the full impact of current high 270 
omega-6 PUFA intakes on future generations will not yet be apparent. 271 
 272 
Word Count: 2838 273 
 274 
Key points: 275 
1. The omega-6 PUFA content of the typical Western diet has increased significantly in 276 
the past few decades 277 
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